カテゴリー： QYResearch, 世界, 医療/バイオ

医療用経皮パッチのグローバル市場2023年：サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他

◆英語タイトル：Global Medical Transdermal Patch Market Research Report 2023
	◆商品コード：QYR23MA8129 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2023年3月 ◆ページ数：103 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD2,900 ⇒換算￥440,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD4,350 ⇒換算￥661,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD5,800 ⇒換算￥881,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の医療用経皮パッチ市場について調査・分析し、世界の医療用経皮パッチ市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他）、用途別セグメント分析（Rxチャンネル、OTCチャンネル）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis、UCB Pharma、Mylan、Teva Pharmaceutical、Nitto Denko、Grunenthal、IBSA Group、GSK、Luye Pharma Group、Pfizer、Chattem、Bayer、Mundipharma、Endo International、Beijing Tide Pharmaceuticalなどが含まれています。世界の医療用経皮パッチ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、医療用経皮パッチ市場規模を推定する際に考慮しました。

・医療用経皮パッチ市場の概要
- 製品の定義
- 医療用経皮パッチのタイプ別セグメント
- 世界の医療用経皮パッチ市場規模：タイプ別分析（サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他）
- 医療用経皮パッチの用途別セグメント
- 世界の医療用経皮パッチ市場規模：用途別分析（Rxチャンネル、OTCチャンネル）
- 世界の医療用経皮パッチ市場規模予測（2018年-2029年）
- 医療用経皮パッチの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 医療用経皮パッチ市場の競争状況およびトレンド

・医療用経皮パッチの地域別市場規模
- 北米の医療用経皮パッチ市場規模（2018年-2029年）
- アメリカの医療用経皮パッチ市場規模（2018年-2029年）
- ヨーロッパの医療用経皮パッチ市場規模（2018年-2029年）
- アジア太平洋の医療用経皮パッチ市場規模（2018年-2029年）
- 中国の医療用経皮パッチ市場規模（2018年-2029年）
- 日本の医療用経皮パッチ市場規模（2018年-2029年）
- 韓国の医療用経皮パッチ市場規模（2018年-2029年）
- インドの医療用経皮パッチ市場規模（2018年-2029年）
- オーストラリアの医療用経皮パッチ市場規模（2018年-2029年）
- 中南米の医療用経皮パッチ市場規模（2018年-2029年）
- 中東・アフリカの医療用経皮パッチ市場規模（2018年-2029年）

・タイプ別セグメント：サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他
- 世界の医療用経皮パッチのタイプ別販売量（2018年-2023年）
- 世界の医療用経皮パッチのタイプ別売上（2018年-2023年）
- 世界の医療用経皮パッチのタイプ別価格

・用途別セグメント：Rxチャンネル、OTCチャンネル
- 世界の医療用経皮パッチの用途別販売量（2018年-2023年）
- 世界の医療用経皮パッチの用途別売上（2018年-2023年）
- 世界の医療用経皮パッチの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis、UCB Pharma、Mylan、Teva Pharmaceutical、Nitto Denko、Grunenthal、IBSA Group、GSK、Luye Pharma Group、Pfizer、Chattem、Bayer、Mundipharma、Endo International、Beijing Tide Pharmaceutical

・産業チェーンと販売チャネルの分析
- 医療用経皮パッチ産業チェーン分析
- 医療用経皮パッチの主要原材料
- 医療用経皮パッチの販売チャネル
- 医療用経皮パッチのディストリビューター
- 医療用経皮パッチの主要顧客

・医療用経皮パッチ市場ダイナミクス
- 医療用経皮パッチの業界動向
- 医療用経皮パッチ市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Medical Transdermal Patch market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Medical Transdermal Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Medical Transdermal Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Medical Transdermal Patch include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grunenthal and IBSA Group, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Transdermal Patch.
The Medical Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Transdermal Patch market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grunenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segment by Type
Methyl Salicylate-based Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Medical Transdermal Patch Market Overview
1.1 Product Overview and Scope of Medical Transdermal Patch
1.2 Medical Transdermal Patch Segment by Type
1.2.1 Global Medical Transdermal Patch Market Value Comparison by Type (2023-2029)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Diclofenac Patch
1.2.4 Nicotine Transdermal Patch
1.2.5 Others
1.3 Medical Transdermal Patch Segment by Application
1.3.1 Global Medical Transdermal Patch Market Value by Application: (2023-2029)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Medical Transdermal Patch Market Size Estimates and Forecasts
1.4.1 Global Medical Transdermal Patch Revenue 2018-2029
1.4.2 Global Medical Transdermal Patch Sales 2018-2029
1.4.3 Global Medical Transdermal Patch Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Transdermal Patch Market Competition by Manufacturers
2.1 Global Medical Transdermal Patch Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Transdermal Patch Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Transdermal Patch Average Price by Manufacturers (2018-2023)
2.4 Global Medical Transdermal Patch Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Transdermal Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Transdermal Patch, Product Type & Application
2.7 Medical Transdermal Patch Market Competitive Situation and Trends
2.7.1 Medical Transdermal Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Transdermal Patch Players Market Share by Revenue
2.7.3 Global Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Transdermal Patch Retrospective Market Scenario by Region
3.1 Global Medical Transdermal Patch Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Transdermal Patch Global Medical Transdermal Patch Sales by Region: 2018-2029
3.2.1 Global Medical Transdermal Patch Sales by Region: 2018-2023
3.2.2 Global Medical Transdermal Patch Sales by Region: 2024-2029
3.3 Global Medical Transdermal Patch Global Medical Transdermal Patch Revenue by Region: 2018-2029
3.3.1 Global Medical Transdermal Patch Revenue by Region: 2018-2023
3.3.2 Global Medical Transdermal Patch Revenue by Region: 2024-2029
3.4 North America Medical Transdermal Patch Market Facts & Figures by Country
3.4.1 North America Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Transdermal Patch Sales by Country (2018-2029)
3.4.3 North America Medical Transdermal Patch Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Transdermal Patch Market Facts & Figures by Country
3.5.1 Europe Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Transdermal Patch Sales by Country (2018-2029)
3.5.3 Europe Medical Transdermal Patch Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Transdermal Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Transdermal Patch Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Transdermal Patch Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Transdermal Patch Market Facts & Figures by Country
3.7.1 Latin America Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Transdermal Patch Sales by Country (2018-2029)
3.7.3 Latin America Medical Transdermal Patch Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Transdermal Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Transdermal Patch Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Transdermal Patch Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Transdermal Patch Sales by Type (2018-2029)
4.1.1 Global Medical Transdermal Patch Sales by Type (2018-2023)
4.1.2 Global Medical Transdermal Patch Sales by Type (2024-2029)
4.1.3 Global Medical Transdermal Patch Sales Market Share by Type (2018-2029)
4.2 Global Medical Transdermal Patch Revenue by Type (2018-2029)
4.2.1 Global Medical Transdermal Patch Revenue by Type (2018-2023)
4.2.2 Global Medical Transdermal Patch Revenue by Type (2024-2029)
4.2.3 Global Medical Transdermal Patch Revenue Market Share by Type (2018-2029)
4.3 Global Medical Transdermal Patch Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Transdermal Patch Sales by Application (2018-2029)
5.1.1 Global Medical Transdermal Patch Sales by Application (2018-2023)
5.1.2 Global Medical Transdermal Patch Sales by Application (2024-2029)
5.1.3 Global Medical Transdermal Patch Sales Market Share by Application (2018-2029)
5.2 Global Medical Transdermal Patch Revenue by Application (2018-2029)
5.2.1 Global Medical Transdermal Patch Revenue by Application (2018-2023)
5.2.2 Global Medical Transdermal Patch Revenue by Application (2024-2029)
5.2.3 Global Medical Transdermal Patch Revenue Market Share by Application (2018-2029)
5.3 Global Medical Transdermal Patch Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Hisamitsu Pharmaceutical Medical Transdermal Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson & Johnson Medical Transdermal Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Medical Transdermal Patch Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Corporation Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 UCB Pharma Medical Transdermal Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Medical Transdermal Patch Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Pharmaceutical Medical Transdermal Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Nitto Denko
6.6.1 Nitto Denko Corporation Information
6.6.2 Nitto Denko Description and Business Overview
6.6.3 Nitto Denko Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nitto Denko Medical Transdermal Patch Product Portfolio
6.7.5 Nitto Denko Recent Developments/Updates
6.8 Grunenthal
6.8.1 Grunenthal Corporation Information
6.8.2 Grunenthal Description and Business Overview
6.8.3 Grunenthal Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Grunenthal Medical Transdermal Patch Product Portfolio
6.8.5 Grunenthal Recent Developments/Updates
6.9 IBSA Group
6.9.1 IBSA Group Corporation Information
6.9.2 IBSA Group Description and Business Overview
6.9.3 IBSA Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.9.4 IBSA Group Medical Transdermal Patch Product Portfolio
6.9.5 IBSA Group Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GSK Medical Transdermal Patch Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Corporation Information
6.11.2 Luye Pharma Group Medical Transdermal Patch Description and Business Overview
6.11.3 Luye Pharma Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Luye Pharma Group Medical Transdermal Patch Product Portfolio
6.11.5 Luye Pharma Group Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Corporation Information
6.12.2 Pfizer Medical Transdermal Patch Description and Business Overview
6.12.3 Pfizer Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Pfizer Medical Transdermal Patch Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Chattem
6.13.1 Chattem Corporation Information
6.13.2 Chattem Medical Transdermal Patch Description and Business Overview
6.13.3 Chattem Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Chattem Medical Transdermal Patch Product Portfolio
6.13.5 Chattem Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Corporation Information
6.14.2 Bayer Medical Transdermal Patch Description and Business Overview
6.14.3 Bayer Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Bayer Medical Transdermal Patch Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 Mundipharma
6.15.1 Mundipharma Corporation Information
6.15.2 Mundipharma Medical Transdermal Patch Description and Business Overview
6.15.3 Mundipharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Mundipharma Medical Transdermal Patch Product Portfolio
6.15.5 Mundipharma Recent Developments/Updates
6.16 Endo International
6.16.1 Endo International Corporation Information
6.16.2 Endo International Medical Transdermal Patch Description and Business Overview
6.16.3 Endo International Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Endo International Medical Transdermal Patch Product Portfolio
6.16.5 Endo International Recent Developments/Updates
6.17 Beijing Tide Pharmaceutical
6.17.1 Beijing Tide Pharmaceutical Corporation Information
6.17.2 Beijing Tide Pharmaceutical Medical Transdermal Patch Description and Business Overview
6.17.3 Beijing Tide Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Beijing Tide Pharmaceutical Medical Transdermal Patch Product Portfolio
6.17.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Transdermal Patch Industry Chain Analysis
7.2 Medical Transdermal Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Transdermal Patch Production Mode & Process
7.4 Medical Transdermal Patch Sales and Marketing
7.4.1 Medical Transdermal Patch Sales Channels
7.4.2 Medical Transdermal Patch Distributors
7.5 Medical Transdermal Patch Customers
8 Medical Transdermal Patch Market Dynamics
8.1 Medical Transdermal Patch Industry Trends
8.2 Medical Transdermal Patch Market Drivers
8.3 Medical Transdermal Patch Market Challenges
8.4 Medical Transdermal Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療用経皮パッチのグローバル市場2023年：サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他(Global Medical Transdermal Patch Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

医療用経皮パッチのグローバル市場2023年：サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp